TY - JOUR
T1 - Treatment of patients with small renal masses
T2 - A survey of the american urological association
AU - Breau, Rodney H.
AU - Crispen, Paul L.
AU - Jenkins, Sarah M.
AU - Blute, Michael L.
AU - Leibovich, Bradley C.
PY - 2011/2
Y1 - 2011/2
N2 - Purpose We surveyed American Urological Association members to determine factors that influence the treatment of patients with small renal masses. Materials and Methods In June 2009 American Urological Association members were solicited to complete an online survey. Respondents were asked their preferred treatment for 8 cases and 3 index patients. In each case computerized tomographic axial and schematic coronal images were provided. Results A total of 759 active urologists with varied training backgrounds and clinical practice settings completed the survey. Tumor size (OR 8.4, 95% CI 7.110.1), tumor depth (OR 19.2, 95% CI 14.825.0) and tumor location (OR 24.0, 95% CI 18.131.8) were markedly associated with preference for radical nephrectomy instead of partial nephrectomy. Fellowship trained urologists (OR 0.4, 95% CI 0.20.6) and urologists at academic hospitals (OR 0.6, 95% CI 0.40.9) were less likely to choose radical nephrectomy. Respondents were more likely to choose active surveillance in an older patient (OR 2.7, 95% CI 2.13.6) or in a patient with comorbidities (OR 10.0, 95% CI 8.012.4). Urologists were less likely to choose active surveillance for a 4 vs 2 cm tumor (OR 0.18, 95% CI 0.150.21). Active surveillance was chosen more often if the tumor was perihilar vs mid kidney (OR 2.0, 95% CI 1.82.3) or polar (OR 2.1, 95% CI 1.92.5). Conclusions There is considerable heterogeneity in the treatment of patients with clinical T1a tumors. Several factors explain these differences as selected treatments are independently associated with tumor, patient and urologist factors.
AB - Purpose We surveyed American Urological Association members to determine factors that influence the treatment of patients with small renal masses. Materials and Methods In June 2009 American Urological Association members were solicited to complete an online survey. Respondents were asked their preferred treatment for 8 cases and 3 index patients. In each case computerized tomographic axial and schematic coronal images were provided. Results A total of 759 active urologists with varied training backgrounds and clinical practice settings completed the survey. Tumor size (OR 8.4, 95% CI 7.110.1), tumor depth (OR 19.2, 95% CI 14.825.0) and tumor location (OR 24.0, 95% CI 18.131.8) were markedly associated with preference for radical nephrectomy instead of partial nephrectomy. Fellowship trained urologists (OR 0.4, 95% CI 0.20.6) and urologists at academic hospitals (OR 0.6, 95% CI 0.40.9) were less likely to choose radical nephrectomy. Respondents were more likely to choose active surveillance in an older patient (OR 2.7, 95% CI 2.13.6) or in a patient with comorbidities (OR 10.0, 95% CI 8.012.4). Urologists were less likely to choose active surveillance for a 4 vs 2 cm tumor (OR 0.18, 95% CI 0.150.21). Active surveillance was chosen more often if the tumor was perihilar vs mid kidney (OR 2.0, 95% CI 1.82.3) or polar (OR 2.1, 95% CI 1.92.5). Conclusions There is considerable heterogeneity in the treatment of patients with clinical T1a tumors. Several factors explain these differences as selected treatments are independently associated with tumor, patient and urologist factors.
KW - carcinoma, renal cell
KW - cross-sectional studies
KW - nephrectomy
UR - http://www.scopus.com/inward/record.url?scp=78651304353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78651304353&partnerID=8YFLogxK
U2 - 10.1016/j.juro.2010.09.092
DO - 10.1016/j.juro.2010.09.092
M3 - Article
C2 - 21168170
AN - SCOPUS:78651304353
SN - 0022-5347
VL - 185
SP - 407
EP - 414
JO - Investigative Urology
JF - Investigative Urology
IS - 2
ER -